Orexo AB Acquires Biolipox AB

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: As previously announced in a press release on October 15, 2007, Orexo AB (STO:ORX) and the principal owners of Biolipox AB have reached an agreement according to which Orexo will acquire Biolipox, an innovative Swedish research-based pharmaceutical company that develops new therapies for inflammatory diseases, including pain management and respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).